The Effect of Ursodeoxycholic Acid (UDCA) on Serum Expression of miR-34a and miR-506 in Patients with Chronic Cholestatic Liver Diseases

Ursodeoxycholic acid (UDCA) is widely used to treat cholestatic liver diseases such as primary biliary cholangitis (PBC) and primary sclerosing cholangitis (PSC), yet its molecular mechanisms remain unclear. This study investigated the impact of long-term UDCA therapy on circulating levels of the mi...

Full description

Bibliographic Details
Published in:Cells
Main Authors: Eliza Cielica, Alicja Łaba, Piotr Milkiewicz, Beata Kruk, Agnieszka Kempinska-Podhorodecka, Patrycja Kłos, Pedro M. Rodrigues, Beatriz Val, Maria J. Perugorria, Jesus M. Banales, Malgorzata Milkiewicz
Format: Article
Language:English
Published: MDPI AG 2025-07-01
Subjects:
ursodeoxycholic acid
cholangitis
miR-34a
miR-506
TREM-2
Online Access:https://www.mdpi.com/2073-4409/14/15/1137

Internet

https://www.mdpi.com/2073-4409/14/15/1137

Similar Items